Skip to main content
SpringerLink
Log in

Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

  1. 1.

    The effects of 6-hydroxydopamine (6-OHDA) and reserpine pretreatment on peripheral neuropeptide Y (NPY)-and noradrenaline (NA)-containing neurons were studied in guinea-pigs.

  2. 2.

    Ten days after 6-OHDA pretreatment, a 60–80% reduction of the NA content was observed in the right atrium of the heart, stellate ganglion and spleen. The content of NPY-like immunoreactivity (LI) was reduced by about 50% in the heart, not changed in the spleen while it increased to 200% of control in the stellate ganglion. Immunohistochemistry showed a pronounced loss of NPY-and tyrosinehydroxylase (TH)-immunoreactive (IR) nerves in the heart but not in the spleen. Increased NPY-IR was seen in axons and cell bodies of the stellate ganglion.

  3. 3.

    Reserpine pretreatment (thereshold dose 0.5 mg x kg−1) caused a dose-and time-dependent reduction of the content of NPY-LI in the heart. A maximal depletion of NPY-LI (about 80%) was observed 5 days after reserpine. Reserpine pretreatment also reduced the content of NPY-LI in the spleen, while no significant change was observed in the adrenal gland or vas deferens. The levels of NPY-LI increased in the stellate ganglion to about 180% of control 5 days after reserpine. Immunohistochemical analysis revealed an almost total loss of NPY-IR nerve fibres in the heart as well as around blood vessels in the lung and skeletal muscle. No detectable changes were observed in perivascular NPY-IR nerves in the spleen, vas deferens or kidney. TH-IR nerves remained unchanged after reserpine, thus indicating that the observed loss of NPY-IR nerves was due to a depletion of NPY and not a degeneration.

  4. 4.

    No change in the levels of substance P-LI was observed in the right atrium 5 days after reserpine.

  5. 5.

    NA was, in contrast to NPY, markedly depleted in all tissues investigated after reserpine treatment. The depletion of NA was more extensive, and occurred more rapidly and at much lower doses as compared to the effects on NPY-LI.

  6. 6.

    Ligations of the sciatic nerve revealed that NPY-LI 4 was transported axonally with a rapid rate (3 mm/h). Reserpine pretreatment significantly increased the amount of accumulated NPY-IR above the ligation, suggesting an increase in axonal transport.

  7. 7.

    High performance liquid chromatography revealed that the NPY-LI consisted of two major peaks in the stellate ganglia, while only one peak closely corresponding to porcine NPY was seen in the right atrium.

  8. 8.

    In conclusion, 6-OHDA pretreatment depletes NPY-LI in certain terminal regions and increases NPY-LI in ganglia. Reserpine induces a tissue-and dose-dependent depletion of NPY-LI in certain terminal areas, while corresponding cell body content and axonal transport of the peptide seem to increase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adrian T, Terenghi G, Brown M, Allen JM, Bacarese-Hamilton Polak J, Bloom S (1983) Neuropeptide Y in Phaeochromocytomas and ganglioneuroblastomas. Lancet, Sept 3:540–542

    Google Scholar 

  • Allen J, Adrian T, Tatemoto K, Polak J, Hughes J, Bloom S (1982) Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically-stimulated mouse vas deferens. Neuropeptides 3:71–77

    Google Scholar 

  • Arnaiz JM, Garcia AG, Horga JF, Kirpekar SM (1978) Tissue and plasma catecholamines and dopamine-β-hydroxylase activity of various animal species after neuronergic sympathetic stimulation. J Physiol 285:515–529

    Google Scholar 

  • Carlsson A (1965) Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Erspamer V (ed) Handbuch Exp Pharm, vol 19. Springer, Berlin Heidelberg New York 529–592

    Google Scholar 

  • Bisby MA, Fillenz M (1971) The storage of endogenous noradrenaline in sympathetic nerve terminals. J Physiol 215:163; 179

    Google Scholar 

  • Fried G (1980) Small noradrenergic storage vesicles isolated from rat vas deferens-biochemical and morphological characterization. Acta Physiol Scand (suppl) 493:1–28

    Google Scholar 

  • Furness JB, Papka R, Della N, Costa M, Eskay R (1982) Substance P-like immunoreactivity in nerves associated with the vascular system of guinea-pigs. Neuroscience 7:447–459

    Google Scholar 

  • Furness JB, Costa M, Emson PC, Håkanson R, Moghimzadeh E, Sundler F, Taylor IL, Chance, RE (1983) Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y-and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tiss Res 234:71–92

    Google Scholar 

  • Gamse R, Holzer P, Lembeck F (1980) Decrease of substance P in primary afferent neurons and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 68:207–213

    Google Scholar 

  • Gilbert RF, Bennett GW, Marsden CA, Emson PC (1981) The effects of 5-hydroxytryptamine depleting drugs on peptides in the ventral spinal cord. Eur J Pharmacol 76:203–210

    Google Scholar 

  • Häggendahl J, Dahlström A (1972) The recovery of the capacity for uptake retention of 3H-noradrenaline in rat adrenergic nerves after reserpine. J Pharm Pharmacol 24:565–574

    Google Scholar 

  • Hökfelt T, Ljungahl Å, Steibusch H, Verhofstad A, Nilsson G, Brodin E, Pernow B, Goldstein M (1978) Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxy-tryptamine-containing neurons in the rat central nervous system. Neuroscience 3:517–534

    Google Scholar 

  • Johansson O (1983) Localization of vasoactive intestinal polypeptide and avian pancreatic polypeptide-like immunoreactivity in the Golgi apparatus of peripheral neurons. Brain Res 262:71–78

    Google Scholar 

  • Jonsson G (1983) Chemical lesioning techniques: Monoamine neurotoxins. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 1. Methods in Chemical Neuroanatomy. Elservier, Amsterdam, pp 463–507

    Google Scholar 

  • Lang R, Hermann K, Dietz R, Gaida W, Ganten D, Kraft K, Unger T (1983) Evidence for the presence of enkephalins in the heart. Life Sci 32:399–406

    Google Scholar 

  • Lundberg JM (1981) Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Acta Physiol Scand 112: (suppl) 496:1–57

    Google Scholar 

  • Lundberg JM, Tatemoto K (1982) Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade. Acta Physiol Scand 116:393–402

    Google Scholar 

  • Lundberg JM, Stjärne L (1984) Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation in rat vas deferens. Acta Physiol Scand 120:477–479

    Google Scholar 

  • Lundberg JM, Hökfelt T, Änggård A, Kimmel J, Goldstein M, Markey K (1980) Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamines in some peripheral and central neurons. Acta Physiol Scand 110:107–109

    Google Scholar 

  • Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116:477–480

    Google Scholar 

  • Lundberg JM, Terenius L, Hökfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neuroscience Letters 42:167–172

    Google Scholar 

  • Lundberg JM, Hua, XY, Franco-Cereceda A (1984a) Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand 121:325–332

    Google Scholar 

  • Lundberg JM, Terenius L, Hökfelt T, Tatemoto K (1984b) Comparative immunohistochemical and biochemical analysis of pancreatic polypeptide-like peptides with special reference to presence of neuropeptide Y in central and peripheral neurons. J Neuroscience 4: (9) 2376–2386

    Google Scholar 

  • Markey KA, Kondo S, Shenkman I, Goldstein M (1980) Purification and characterization of tyrosine hydroxylase from a clonal phaeochromocytoma cell line. Mol Pharmacol 17:79–85

    Google Scholar 

  • Oishi R, Mishima S, Kuriyama H (1983) Determination of norepinephrine and its metabolites released from rat vas deferens using high-performance liquid chromatography with electrochemical detection. Life Sci 32:933–940

    Google Scholar 

  • Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485–5489

    Google Scholar 

  • Thoenen H, Tranzer JP (1968) Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. NS Arch Pharm Exp Path 261:271–288

    Google Scholar 

  • Thoenen H, Mueller R, Axelrod J (1969) Increased tyrosine hydroxylase activity after drug induced alteration of sympathetic transmission. Nature 211:1264

    Google Scholar 

  • Viveros OH, Arqueros L, Connett RJ, Kirshner N (1969) Mechanism of secretion from the adrenal medulla. IV. The fate of the storage vesicles following insulin and reserpine administration. Mol Pharm 5:69–82

    Google Scholar 

  • Wilson SP, Chang U-J, Viveros OH (1980a) Synthesis of enkephalins by adrenal medullary chromaffin cells: Reserpine increases incorporation of radiolabelled amino acids. Proc Natl Acad Sci USA; 77:4364–4368

    Google Scholar 

  • Wilson SP, Klein RL, Chang U-J, Gasparis MS, Viveros OH, Yang, WH (1980b). Are opioid peptide co-transmitters in noradrenergic vesicles of sympathetic nerves. Nature 288:707–709

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Karolinska Institute, Box 60400, S-104 01, Stockholm, Sweden

    Jan M. Lundberg & Anders Franco-Cereceda

  2. Department of Experimental and Clinical Pharmacology, University of Graz, Universitätsplatz 4, A-8010, Graz, Austria

    Alois Saria

  3. Department of Histology, Karolinska Institutet, Box 60400, S-104 01, Stockholm, Sweden

    Tomas Hökfelt

  4. Department of Pharmacology, University of Uppsala, Uppsala, Sweden

    Lars Terenius

  5. Department of Psychiatry, New York University Medical Center, New York, NY, USA

    Menek Goldstein

Authors
  1. Jan M. Lundberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alois Saria
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anders Franco-Cereceda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomas Hökfelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lars Terenius
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Menek Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lundberg, J.M., Saria, A., Franco-Cereceda, A. et al. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 331–340 (1985). https://doi.org/10.1007/BF00515563

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00515563

Key words

Search

Navigation